We are live on ! Find out more
ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

6 hedge funds and large institutions have $7.22K invested in ZyVersa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more funds holding

Funds holding: 46 (+2)

0.94% less ownership

Funds ownership: 1.23%0.29% (-0.94%)

81% less capital invested

Capital invested by funds: $38.7K → $7.22K (-$31.5K)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$6.16K +$5.99K +1,867 +267%
UBS Group
2
UBS Group
Switzerland
$1.04K +$1.39K +433 New
Bank of America
3
Bank of America
North Carolina
$19 +$3 +1 +14%
JP Morgan Chase
4
JP Morgan Chase
New York
$2
Morgan Stanley
5
Morgan Stanley
New York
$2 +$3 +1 New
ACM
6
ADAR1 Capital Management
Texas
-$36.1K -9,598 Closed
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
+$167 +52 New